New Medicine Service toolkit
This four module NMS Toolkit will provide you with all the information you need to complete the ‘self-assessment of readiness' that must be submitted before you can offer the New Medicine Service..
What do I need to do?
To purchase the four module NMS Toolkit for £10+VAT (£12), you can Buy Online or call 020 7921 8425
How will I benefit?
Properly completing the course means you can download a completed self-assessment certificate which you only need to sign and date…
In addition, each module comes with its own CPD log sheet, enabling you to use it as a CPD entry in your ‘Plan and Record' portfolio at uptodate.org.uk.
What will i learn?
The four modules in the NMS Toolkit cover:
· Module 1: An introduction to the NMS, outlining the purpose of the service and its aims and outcomes
· Module 2: The service specification and how to deliver the NMS effectively
· Module 3: A five point guide to getting the most out of NMS consultations – face-to-face and over the phone
· Module 4: Essential counselling points for the four targeted therapy areas for the NMS
To complete the assessment for each module online go to My CPD. Find NMS Toolkit in your course list and click on 'View Exams'. Use the menu options on the Exam page to download your CPD logsheet, and print or e-mail a certificate when you have completed the assessment.
Use the menu option on the Course page to download your ‘Self-assessment of Readiness' certificate
Phone: 020 7921 8425
This module sets out what the criteria are for you to provide the sevice, and give you an understanding of the purpose and background of the service, and the aims and intended outcomes of the service
This module sets out the service specification and all aspects of how to deliver the service effectively.
A five point guide to the setting the scene and using appropriate counselling skills to ensure you get the best results from NMS consultations, whether face-to-face or over the phone.
Essential counselling points for patients on newly prescribed medicines in the four NMS target areas of asthma and COPD, type 2 diabetes, anti coagulant therapy, and hypertension.